This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (2)  • Contact me when this article is cited  Related Content  • Related articles  • Similar articles in JAMA  Topic Collections  • Surgical Interventions  • Women's Health, Other  • Randomized Controlled Trial  • Alert me on articles by topic

Trials and Tribulations

Roy M. Pitkin, MD; James R. Scott, MD

JAMA. 2004;291:1503-1504.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

The randomized controlled trial (RCT), introduced into clinical research more than 50 years ago, has assumed increasing importance in evaluating medical interventions. Most studies comparing randomized and nonrandomized trials addressing the same question have found that RCTs generally yield less favorable assessments of treatment efficacy than the nonrandomized trials.¹ Although this conclusion is not quite unanimous,² there has been increasing recognition of the importance of random assignment in medical research and the RCT now occupies a prominent position in the hierarchy of evidence on which to base clinical judgments.³ In addition to random assignment, allocation concealment and other features of experimental design are also critical for proper conduct of an RCT.⁴ Attention to these essential aspects improves study quality⁵ and, presumably, the trust clinicians can place in the findings.

High-quality RCTs are challenging to perform. Under the best circumstances, recruitment can be . . . [Full Text of this Article]

Author Affiliations: Department of Obstetrics and Gynecology, University of California, Los Angeles (Dr Pitkin) and Department of Obstetrics and Gynecology, University of Utah, Salt Lake City (Dr Scott).

RELATED ARTICLES

Effect of Hysterectomy vs Medical Treatment on Health-Related Quality of Life and Sexual Functioning: The Medicine or Surgery (Ms) Randomized Trial
Miriam Kuppermann, R. Edward Varner, Robert L. Summitt, Jr, Lee A. Learman, Christine Ireland, Eric Vittinghoff, Anita L. Stewart, Feng Lin, Holly E. Richter, Jonathan Showstack, Stephen B. Hulley, and A. Eugene Washington
JAMA. 2004;291(12):1447-1455.
ABSTRACT | FULL TEXT  

Clinical Outcomes and Costs With the Levonorgestrel-Releasing Intrauterine System or Hysterectomy for Treatment of Menorrhagia: Randomized Trial 5-Year Follow-up
Ritva Hurskainen, Juha Teperi, Pekka Rissanen, Anna-Mari Aalto, Seija Grenman, Aarre Kivelä, Erkki Kujansuu, Sirkku Vuorma, Merja Yliskoski, and Jorma Paavonen
JAMA. 2004;291(12):1456-1463.
ABSTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Is Hysterectomy the Best Treatment for Abnormal Uterine Bleeding?
JWatch General 2004;2004:2-2.
FULL TEXT